Close this search box.
Subscriber Log In

In Case You Missed It: Three Things We Learned From Our Orphan Drug Webinar


Missed our webinar on orphan drugs and the impact of the Inflation Reduction Act? Well, you missed a lot but here are a few takeaways to help you catch up. And the full webinar is available on demand. Drugs for orphan indications are a fascinating area of the pharma industry. Our recent report on the […]

Orphan Drugs: About as Niche as a Flat White


To those beyond the world of biopharma, the term “orphan drug” sounds a bit sad, a bit forgotten. But to those involved in the industry, the superior return on investment, supportive regulatory environment and rates of growth mean that these orphans are anything but tragic. We’ve just published our latest report on the state of […]